20 ML MS 25 MG/ML Injection [Mitigo]
- RxCUI
- 2055311
- RxNorm name
- 20 ML MS 25 MG/ML Injection [Mitigo]
- Display name
- 20 ML MS 25 MG/ML Injection [Mitigo]
- Full name
- 20 ML MS 25 MG/ML Injection [Mitigo]
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MITIGO | MORPHINE SULFATE | Piramal Critical Care, Inc. | 728f3d83-9a63-0c1f-e053-2a91aa0ac7db | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | 2055311 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 728f3d83-9a63-0c1f-e053-2a91aa0ac7db | MITIGO 500 MG in 20 ML Injection [PSN] · 20 ML morphine sulfate 25 MG/ML Injection [Mitigo] [SBD] · 20 ML Mitigo 25 MG/ML Injection [SY] · 20 ML MS 25 MG/ML Injection [Mitigo] [SY] · Mitigo 500 MG per 20 ML Injection [SY] | 5 | 19 | These highlights do not include all the information needed to use MITIGO® safely and effectively. See full prescribing information for MITIGO ® . MITIGO ® (morphine sulfate injection), Preservative-free, injectable solution, for intrathecal or epidural infusion, using a continuous microinfusion device, CII Initial U.S. Approval: 1941 | 20260219 |